Adrenergic Antagonists: Pharmacological Actions of <U+0251>-Receptor Blockers. :: SCD d'Orléans

Adrenergic Antagonists: Pharmacological Actions of <U+0251>-Receptor Blockers.

Adrenergic Antagonists: Pharmacological Actions of <U+0251>-Receptor Blockers.

Gorde:

Xehetasun bibliografikoak
Formatua:	Article de revue numérique
Hizkuntza:	Indéterminée
Argitaratua:	Journal of Visualized Experiments (JoVE) 2023.
Sarrera elektronikoa:	Accès Université d'Orléans
Oharra:	JOVE Education
Variante du titre:	Adrenergic Antagonists: Pharmacological Actions of -Receptor Blockers

Antzeko izenburuak

Adrenergic Antagonists: <U+0251> and nb-Receptor Blockers.
Argitaratua: (2023)

Adrenergic Antagonists: Chemistry and Classification of <U+0251>-Receptor Blockers.
Argitaratua: (2023)

Adrenergic Antagonists: Pharmacological Actions of nb-Receptor Blockers.
Argitaratua: (2023)

Adrenergic Receptors: <U+0251> Subtype.
Argitaratua: (2023)

Adrenergic Antagonists: Chemistry and Classification of nb-Receptor Blockers.
Argitaratua: (2023)

Cholinergic Antagonists: Pharmacological Actions.
Argitaratua: (2023)

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions.
Argitaratua: (2023)

Adrenergic Receptors (Adrenoceptors): Classification.
Argitaratua: (2023)

Adrenergic Receptors: nb Subtype.
Argitaratua: (2023)

Drug-Receptor Interaction: Antagonist.
Argitaratua: (2023)

Antiarrhythmic Drugs: Class II Agents as nb-Adrenergic Blockers.
Argitaratua: (2023)

Antiasthma Drugs: Muscarinic Receptor Antagonists.
Argitaratua: (2023)

Antihypertensive Drugs: Angiotensin II Receptor Blockers.
Argitaratua: (2023)

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists.
Argitaratua: (2023)

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists.
Argitaratua: (2023)

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists.
Argitaratua: (2023)

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists.
Argitaratua: (2023)

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists.
Argitaratua: (2023)

Insomnia and beyond - Exploring the therapeutic potential of orexin receptor antagonists
nork: Michel Alexander Steiner, et al.
Argitaratua: (2021)

Pharmacogenetics of Drug Targets: ??-Adrenergic Receptors, Apo E, Thymidylate Synthase.
Argitaratua: (2026)

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists.
Argitaratua: (2023)

Depolarizing Blockers: Mechanism of Action.
Argitaratua: (2023)

Adrenergic Agonists: Mixed-Action Agents.
Argitaratua: (2023)

Enzymes Regulating the Homeostasis of Agonists and Antagonists of the N-Methyl D-Aspartate Receptors
Argitaratua: (2021)

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers.
Argitaratua: (2023)

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists.
Argitaratua: (2023)

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action.
Argitaratua: (2023)

Antihypertensive Drugs: Action of nb1 Blockers.
Argitaratua: (2023)

Antihypertensive Drugs: Action of Calcium Channel Blockers.
Argitaratua: (2023)

Adrenergic Neurons: Neurotransmission.
Argitaratua: (2023)

Depolarizing Blockers: Pharmocokinetics.
Argitaratua: (2023)

Cholinergic Antagonists: Pharmacokinetics.
Argitaratua: (2023)

Adrenergic Agonists: Therapeutic Classification.
Argitaratua: (2023)

Adrenergic Agonists: Therapeutic Uses.
Argitaratua: (2023)

The Example and its Antagonist
Argitaratua: (2026)

Antagonist, Type, or Deviation?
nork: Voříšek, Michael
Argitaratua: (2008)

Effect of beta-adrenergic agonists in animal production and their mode of action
nork: L.O. FIEMS
Argitaratua: (1987)

Pharmacological Reports.

Pharmacological Research.

Pharmacological Research.

© 2021-2023 • Université d'Orléans, Service Commun de Documentation, 6 rue de Tours, 45072 Orléans cedex 2
+33(0) 2 38 41 71 84 • https://scd.univ-orleans.fr • Mentions légales